SIOP PODC: Recommendations for supportive care of children with cancer in a low-income setting

Pediatric Blood and Cancer

Volumn 60, Issue 6, 2013, Pages 899-904

  Israels, Trijn ^a   Renner, Lorna ^b   Hendricks, Marc ^c   Hesseling, Peter ^d   Howard, Scott ^e   Molyneux, Elizabeth ^f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GHANA   (Ghana)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Africa; Developing countries; Febrile neutropenia; Low income countries; Malnutrition; Supportive care

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMITRIPTYLINE; AMPICILLIN; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; CEFTRIAXONE; CHLORAL HYDRATE; CIPROFLOXACIN; COTRIMOXAZOLE; CRYSTAL VIOLET; DEXAMETHASONE; DIAZEPAM; DIPHENHYDRAMINE; FLUCONAZOLE; GENTAMICIN; IBUPROFEN; KETAMINE; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; ONDANSETRON; PARACETAMOL; TROPISETRON;

ANALGESIA; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER THERAPY; CANDIDIASIS; CHILD CARE; CHILDHOOD CANCER; DRUG DOSE INCREASE; EXTRAPYRAMIDAL SYMPTOM; FEBRILE NEUTROPENIA; FEVER; HERPETIC STOMATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LOWEST INCOME GROUP; MALARIA; MUCOSA INFLAMMATION; NEUROPATHIC PAIN; NURSING CARE; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOCIAL SUPPORT; VOMITING;

CHILD; HEALTH RESOURCES; HUMANS; NEOPLASMS; POVERTY; SOCIAL SUPPORT;

EID: 84876440338     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24501     Document Type: Article

References (64)

1. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: A descriptive study. Lancet Oncol 2008; 9: 721-729.
2. Israels T, Borgstein E, Pidini D, et al. Management of children with a Wilms tumour in Malawi, sub-Saharan Africa. J Pediatr Hematol Oncol 2012; 34: 606-610.
3. Hesseling PB, Njume E, Kouya F, et al. The cameroon 2008 Burkitt lymphoma protocol: Improved event-free survival with treatment adapted to disease stage and the response to induction therapy. Pediatr Hematol Oncol 2012; 29: 119-129.
4. Israels T. Wilms tumor in Africa: Challenges to cure. Pediatr Blood Cancer 2012; 58: 3-4.
5. Abuidris DO, Elimam ME, Nugud FM, et al. Wilms tumour in Sudan. Pediatr Blood Cancer 2008; 50: 1135-1137.
6. Meremikwu MM, Ehiri JE, Nkanga DG, et al. Socioeconomic constraints to effective management of Burkitt's lymphoma in south-eastern Nigeria. Trop Med Int Health 2005; 10: 92-98.
7. Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: Position statement of a SIOP PODC Working Group. Lancet Oncol 2011; 12: 719-720.
8. Israels T, Chirambo C, Caron H, et al. The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer 2008; 51: 639-642.
9. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291: 2471-2475.
10. Hesseling P, Broadhead R, Mansvelt E, et al. The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer 2005; 44: 245-250.
11. Israels T, Moreira C, Scanlan T, et al. SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatr Blood Cancer 2012; 60: 5-11.
12. Hesseling PB, Israels T, Harif M, et al. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting. Pediatr Blood Cancer 2013; 60: 357-362.
13. Molyneux E, Davidson A, Orem J, et al. The management of children with Kaposi sarcoma in resource limited settings. Pediatr Blood Cancer 2012; DOI: 10.1002/pbc.24408 [Epub ahead of print].
14. Chantada G, Luna-Fineman S, Sitorus RS, et al. SIOP-PODC graduated-intensity retinoblastoma guidelines writing committee. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries. Pediatr Blood Cancer 2013; DOI: 10.1002/pbc.24468 [Epub ahead of print].
15. Zitella LJ, Friese CR, Hauser J, et al. Putting evidence into practice: Prevention of infection. Clin J Oncol Nurs 2006; 10: 739-750.
16. World Health Organization (WHO). WHO guidelines on Hand Hygiene in Health Care. Geneva: WHO; 2009. pp. 6-24.
17. Kendall A, Landers T, Kirk J, et al. Point-of-care hand hygiene: Preventing infection behind the curtain. Am J Infect Control 2012; 40: S3-S10.
18. Sexton AR. Best practices for an insecticide-treated bed net distribution programme in sub-Saharan eastern Africa. Malar J 2011; 10: 157.
19. Gray DM, Zar HJ. Community-acquired pneumonia in HIV-infected children: A global perspective. Curr Opin Pulm Med 2010; 16: 208-216.
20. Day SW, Garcia J, Antillon F, et al. A sustainable model for pediatric oncology nursing education in low-income countries. Pediatr Blood Cancer 2012; 58: 163-166.
21. Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011; 117: 4788-4795.
22. Israels T, van de Wetering MD, Hesseling P, et al. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 2009; 53: 47-52.
23. Santolaya ME. Supportive care in children. Curr Opin Oncol 2010; 22: 323-329.
24. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: 427-431.
25. Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008; 32: S30-S33.
26. Hesseling P, Molyneux E, Kamiza S, et al. Endemic Burkitt lymphoma: A 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr 2009; 29: 29-34.
27. Unicef, State of the world's children, 2012.
28. Israels T, Chirambo C, Caron HN, et al. Nutritional status at admission of children with cancer in Malawi. Pediatr Blood Cancer 2008; 51: 626-628.
29. Norman K, Pichard C, Lochs H, et al. Prognostic impact of disease-related malnutrition. Clin Nutr 2008; 27: 5-15.
30. Oguz A, Karadeniz C, Pelit M. Arm anthropometry in evaluation of malnutrition in children with cancer. Ped Hematol Oncol 1999; 16: 35-41.
31. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34: 2540-2545.
32. Israels T, Borgstein E, Jamali M, et al. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatr Blood Cancer 2009; 53: 1221-1226.
33. Manary MJ. Local production and provision of ready-to-use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food Nutr Bull 2006; 27: S83-S89.
34. Jordan K, Roila F, Molassiotis A, et al. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009. Support Care Cancer 2011; 19: S37-S42.
35. Collins JJ. Cancer pain management in children. Eur J Pain 2001; 5: 37-41.
36. Kamuhabwa A, Ezekiel D. Rational use and effectiveness of morphine in the palliative care of cancer patients at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania. Tanzan J Health Res 2009; 11: 170-174.
37. D'Agostino J, Terndrup TE. Chloral hydrate versus midazolam for sedation of children for neuroimaging: A randomized clinical trial. Pediatr Emerg Care 2000; 16: 1-4.
38. Wheeler DS, Jensen RA, Poss WB. A randomized, blinded comparison of chloral hydrate and midazolam sedation in children undergoing echocardiography. Clin Pediatr (Phila) 2001; 40: 381-387.
39. Molyneux E. Post-conference thoughts from Malawi. Lancet 2003; 362: 2117.
40. Tapsfield JB, Jane BM. Hospital based palliative care in sub-Saharan Africa; a six month review from Malawi. BMC Palliat Care 2011; 10: 12.
41. Lavy V. Presenting symptoms and signs in children referred for palliative care in Malawi. Palliat Med 2007; 21: 333-339.
42. Baker JN, Hinds PS, Spunt SL, et al. Integration of palliative care practices into the ongoing care of children with cancer: Individualized care planning and coordination. Pediatr Clin North Am 2008; 55: 223-250.
43. van de Wetering MD, Schouten-van Meeteren NY. Supportive care for children with cancer. Semin Oncol 2011; 38: 374-379.
44. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev 2010; 11: CD003940.
45. Berrios RL, Arbiser JL. Effectiveness of gentian violet and similar products commonly used to treat pyodermas. Dermatol Clin 2011; 29: 69-73.
46. Nyst MJ, Perriens JH, Kimputu L, et al. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop 1992; 72: 45-52.
47. Glenny AM, Gibson F, Auld E, et al. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 2010; 46: 1399-1412.
48. Orem J, Maganda A, Mbidde EK, et al. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer 2009; 52: 455-458.
49. Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: Emerging challenges in the era of highly active antiretroviral therapy. Oncologist 2005; 10: 412-426.
50. Little RF, Gutierrez M, Jaffe ES, et al. HIV-associated non-Hodgkin lymphoma: Incidence, presentation, and prognosis. JAMA 2001; 285: 1880-1885.
51. Deeken JF, Tjen AL, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis 2012; 55: 1228-1235.
52. Dunleavy K, Wilson WH. How I treat HIV-associated lymphoma. Blood 2012; 119: 3245-3255.
53. Ratner L, Lee J, Tang S, et al. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 2001; 19: 2171-2178.
54. Vaccher E, Spina M, di GG, et al. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma. Cancer 2001; 91: 155-163.
55. Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002; 100: 1984-1988.
56. World Health Organization. Global tuberculosis control: WHO report 2010. Geneva: WHO; 2010.
57. Wessels G, Hesseling PB, Gie RP, et al. The increased risk of developing tuberculosis in children with malignancy. Ann Trop Paediatr 1992; 12: 277-281.
58. Aksoy U, Erbay A, Akisu C, et al. Intestinal parasites in children with neoplasms. Turk J Pediatr 2003; 45: 129-132.
59. Jayaraman S, Chalabi Z, Perel P, et al. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 433-442.
60. Tagny CT, Mbanya D, Tapko JB, et al. Blood safety in Sub-Saharan Africa: A multi-factorial problem. Transfusion 2008; 48: 1256-1261.
61. Gibson BE, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124: 433-453.
62. Cheema B, Molyneux EM, Emmanuel JC, et al. Development and evaluation of a new paediatric blood transfusion protocol for Africa. Transfus Med 2010; 20: 140-151.
63. World Health Organization. Clinical use of blood in medicine, obstetrics, paediatrics, surgery and anaesthesia, trauma and burns. Geneva: WHO; 2001. p. 337.
64. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003; 362: 706-708.